Mechanism of Action
Helical Membrane Insertion
Ponericins form amphipathic alpha-helices in hydrophobic environments. The positively charged residues facilitate electrostatic attraction to anionic bacterial membranes, while the hydrophobic face drives membrane insertion. This leads to pore formation or toroidal disruption of the lipid bilayer.
Selectivity Mechanism
Selectivity for prokaryotic over eukaryotic membranes arises from the preferential interaction with phosphatidylglycerol and cardiolipin present in bacterial membranes versus the cholesterol-rich composition of mammalian cells. Cholesterol reduces peptide insertion efficiency.
Research Summary
Antibacterial Spectrum
PreclinicalPonericin G1 is active against gram-positive and gram-negative bacteria including S. aureus, B. subtilis, and E. coli. Several analogs within the ponericin family display different selectivity profiles against bacteria versus insects, informing the development of targeted therapeutics.
Structural Analogs
PreclinicalFourteen ponericins (G1-G7, W1-W4, L1-L3) have been characterized with varying amino acid sequences and activity profiles. Structure-activity studies have identified residues critical for potency and selectivity, providing a platform for optimized AMP design.
Calculate your Ponericin dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Antibacterial MIC | 2-16 mcg/mL | Single | Broth assay |
| Membrane disruption | 5-20 mcg/mL | Single | Liposome leakage |
Research only. No human protocols established.
Interactions
Safety Profile
Ponericins display some hemolytic activity at higher concentrations, a common challenge for cationic AMPs. Structural optimization of the hydrophobic face reduces toxicity while maintaining antibacterial potency. No human safety data available.
References
- [1]Orivel J et al. (2001). Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Journal of Biological Chemistry, 276(21), 17823-17829.
- [2]Rifflet A et al. (2012). Identification and characterization of a novel antimicrobial peptide from the venom of the ant Tetramorium bicarinatum. Peptides, 38(2), 363-370.